Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- KC1086Phase 21 trial
Beijing Konruns Pharmaceutical Co., Ltd. · HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- KeynatinibTL007Phase 21 trial
Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases
- KH617Phase 21 trial
Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma
- KHN922Phase 21 trial
Chengdu Kanghong Biotech Co., Ltd. · Advanced Solid Tumors Cancer
- KK2430Phase 21 trial
Kyowa Kirin Co., Ltd. · Hematologic Neoplasms
- KL590586Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumor
- KN035Phase 21 trial
3D Medicines (Sichuan) Co., Ltd. · Solid Tumor
- KN713Phase 21 trial
New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- KQB198Phase 21 trial
Kumquat Biosciences Inc. · GIST - Gastrointestinal Stromal Tumor, GIST, GIST Metastatic Cancer
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- KY-0301Phase 21 trial
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. · Solid Tumors
- LAT010Phase 21 trial
Latticon Antibody Therapeutics, Inc · Advanced Solid Tumor
- LBL-033Phase 21 trial
Nanjing Leads Biolabs Co.,Ltd · Advanced Malignant Tumors
- LCB02APhase 21 trial
LigaChem Biosciences, Inc. · Advanced Solid Tumors
- LCB84Phase 21 trial
LigaChem Biosciences, Inc. · Advanced Solid Tumors
- leronlimabPRO 140Phase 21 trial
CytoDyn, Inc. · Metastatic Colorectal Cancer (mCRC)
- Letetresgene autoleucellete-cel, GSK3377794Phase 21 trial
USWM CT, LLC · Neoplasms
- LEU011Phase 21 trial
Leucid Bio · Tumor, Solid
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- LinrodostatBMS-986205Phase 21 trial
Bristol Myers Squibb · Advanced Cancer
- LM-2417Phase 21 trial
LaNova Medicines Limited · Advanced Solid Tumor
- LM-350Phase 21 trial
LaNova Medicines Limited · Malignant Tumors
- LM101Phase 21 trial
LaNova Medicines Limited · Malignant Tumors
- LP-184Phase 21 trial
Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM
- LPM6690176Phase 21 trial
Luye Pharma Group Ltd. · Metastatic Colorectal Cancer (mCRC)
- LSAM-CisplatinPhase 21 trial
NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) · Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG), Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
- LTT462Phase 21 trial
Novartis · Melanoma
- Lu-177-DGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- LUM015Phase 21 trial
Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer
- LY2784544Phase 21 trial
Eli Lilly · Neoplasms, Hematologic
- LY3537021Phase 21 trial
Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions
- LYL273Phase 21 trial
Lyell Immunopharma, Inc. · Colorectal Cancer
- LYT-200Phase 21 trial
PureTech · Metastatic Cancer, Solid Tumor, Head and Neck Cancer
- M6223Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MDX2001Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer
- MDX2004Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Advanced Tumors
- MerestinibLY2801653Phase 21 trial
Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer
- MHB009CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor
- MHB034CPhase 21 trial
Minghui Pharmaceutical (Shanghai) LTD · Advanced Malignant Solid Tumor
- MHB042CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor
- MHB046CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Solid Cancer
- MHB048CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
- MIT-001Phase 21 trial
MitoImmune Therapeutics · Head and Neck Squamous Cell Carcinoma, Oral Mucositis
- MIV-818Phase 21 trial
Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases
- MK-1200Phase 21 trial
Merck & Co. · Advanced Solid Tumors
- MK-2750Phase 21 trial
Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm
- ML-016iNPG-pDoxPhase 21 trial
BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement
- MocaciclibQ901Phase 21 trial
Qurient Co., Ltd. · Advanced Cancer, Metastatic Cancer
- MPB-1734DMB025Phase 21 trial
MegaPro Biomedical Co. Ltd. · Solid Tumor, Unspecified, Adult
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.